Quantitatively monitoring acute ischemic stroke patients post recombinant tissue plasminogen activator treatment

Quantitatively monitoring acute ischemic stroke patients post recombinant tissue plasminogen activator treatment

Abstract Background and aims Thrombolytic therapy is widely used to treat acute ischemic stroke (AIS) patients. As intracerebral hemorrhage is a life‐threatening complication of this therapy, monitoring the fibrinolytic and coagulation systems is imperative. However, existing studies on plasmin inhi...

Full description

Bibliographic Details
Main Authors: Yonge Liu, Jingting Ma, Qiyang Shi, Shimeng Xin, Haojia Yu, Zilong Liu, Chunsong Pang, Feng Dong, Jinghan Wang
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Health Science Reports
Subjects:
acute ischemic stroke
D‐dimer
IV alteplase
plasmin‐a2 plasmin inhibitor complex
thrombin‐antithrombin complex
Online Access:https://doi.org/10.1002/hsr2.218

Internet

https://doi.org/10.1002/hsr2.218

Similar Items